Skip to main content
Insights Perspectives

Why patient capital is the missing ingredient in African fintech

The companies reshaping financial access aren't built in a single funding cycle. They're built by investors willing to stay for the long run.

A Moniepoint agent processes a payment at a market stall in Lagos.

Across East and West Africa, a new generation of financial companies is reaching customers the formal sector never could. But the businesses that endure share something less visible than a great product — investors who measure success in years, not quarters.

The story most often told about fintech is one of speed: a clever app, a viral launch, a chart that bends sharply upward. It makes for good headlines, but it rarely matches what we see on the ground. The companies solving real problems — getting credit to a market trader, moving a salary safely, banking a business that has only ever dealt in cash — grow on the timeline of trust, not the timeline of a funding round.

That mismatch is where good companies quietly stall. A team builds something genuinely useful, raises against optimistic projections, then spends the next eighteen months chasing growth numbers the market isn’t ready to give. The product was never the problem. The expectations around it were.

What patient capital actually means

Patient capital is not a softer kind of money. It is money with a clearer view of where value comes from. It accepts that distribution in these markets is built agent by agent and town by town, that regulatory trust compounds slowly, and that the deepest moats are the ones that take the longest to dig.

The hardest problems in financial access take a decade to solve. The capital behind them has to be willing to wait.

Brian Waswani Odhiambo, Partner

Three things long-term investors look for

When we evaluate a company we expect to hold for the better part of a decade, a few signals matter more than the rest:

  • A founding team that understands its customers as neighbours, not as a market segment on a slide.
  • A model whose economics improve as it scales, rather than one propped up by ever-larger rounds.
  • A reason to exist that holds even when the funding environment turns cold — because eventually it will.

Get those three right and the growth tends to follow on its own terms. Get them wrong and no amount of capital, patient or otherwise, will fix it. The investors who matter most to a company are the ones still in the room when the easy money has left.

Perspectives
Share
Newsletter

Stay close to the markets we know best

We respect your privacy. Unsubscribe anytime.